Request for Proposals: $100,000 Awards for Translational Research
The Wallace H. Coulter Translational Research Partners II (TPII) Program at the University of Pittsburgh funds translational research projects in healthcare, with the goal of accelerating the introduction of new technologies into patient care to address unmet clinical needs. Examples of desirable translational research projects and outcomes include systems and devices for the improved diagnosis and treatment of disease including both diagnostic and therapeutic solutions.
Application criteria include:
- One Co‐PI with a faculty appointment in the Department of Bioengineering
- One Co‐PI who is a clinical practitioner in Pitt’s Schools of the Health Sciences
- Student‐sourced projects are eligible to apply
- Research must translate to applications in health care
- Outcome benefits patients when technology/therapy is commercialized
Evaluation of each proposal will be on the basis of scientific and clinical merit, potential health care impact and significance, experience of the investigative co‐PIs and collaborators, timeline and pathway to commercialization, and potential for obtaining further financial investment to translate the particular innovative technology to a healthcare solution.
The project funding period is July 1, 2013, through June 30, 2014. The deadline for your letter of intent is November 7, 2012. This 1-page document must identify the business potential of the proposed healthcare innovation.
Please contact Lindsay Rodzwicz, Coulter Program Administrator, with your questions. She can be reached at (412) 624‐3495 or email: email@example.com.
Illustration: The Wallace H. Coulter Translational Research Partners II (TPII) Program at the University of Pittsburgh.